Infographic: Efficacy and Safety of High-Dose Intravitreal Aflibercept 8 mg in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Week 96 Results from the Phase 3 PULSAR Trial
Jean-François Korobelnik, Sergio Leal, Paolo Lanzetta, on behalf of the Korean Familial Hypercholesterolemia (KFH) Registry Investigators et autres